These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22294242)

  • 1. Effect of radiation on the expression of osteoclast marker genes in RAW264.7 cells.
    Yang B; Zhou H; Zhang XD; Liu Z; Fan FY; Sun YM
    Mol Med Rep; 2012 Apr; 5(4):955-8. PubMed ID: 22294242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning and characterization of osteoclast precursors from the RAW264.7 cell line.
    Cuetara BL; Crotti TN; O'Donoghue AJ; McHugh KP
    In Vitro Cell Dev Biol Anim; 2006; 42(7):182-8. PubMed ID: 16948499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sargachromanol G inhibits osteoclastogenesis by suppressing the activation NF-κB and MAPKs in RANKL-induced RAW 264.7 cells.
    Yoon WJ; Kim KN; Heo SJ; Han SC; Kim J; Ko YJ; Kang HK; Yoo ES
    Biochem Biophys Res Commun; 2013 May; 434(4):892-7. PubMed ID: 23611776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
    Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
    J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of mechanical strain on osteoclastogenesis and osteoclast-related gene expression in RAW264.7 cells.
    Xu XY; Guo C; Yan YX; Guo Y; Li RX; Song M; Zhang XZ
    Mol Med Rep; 2012 Aug; 6(2):409-15. PubMed ID: 22580758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunosuppressant rapamycin, alone or with transforming growth factor-beta, enhances osteoclast differentiation of RAW264.7 monocyte-macrophage cells in the presence of RANK-ligand.
    Shui C; Riggs BL; Khosla S
    Calcif Tissue Int; 2002 Nov; 71(5):437-46. PubMed ID: 12202955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gingipains promote RANKL-induced osteoclastogenesis through the enhancement of integrin β3 in RAW264.7 cells.
    Mo W; Luo H; Wu J; Xu N; Zhang F; Qiu Q; Zhu W; Liang M
    J Mol Histol; 2020 Apr; 51(2):147-159. PubMed ID: 32193744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-magnitude high-frequency vibration inhibits RANKL-induced osteoclast differentiation of RAW264.7 cells.
    Wu SH; Zhong ZM; Chen JT
    Int J Med Sci; 2012; 9(9):801-7. PubMed ID: 23136544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis.
    Kimachi K; Kajiya H; Nakayama S; Ikebe T; Okabe K
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Mar; 383(3):297-308. PubMed ID: 21225243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption.
    Kim MS; Day CJ; Selinger CI; Magno CL; Stephens SR; Morrison NA
    J Biol Chem; 2006 Jan; 281(2):1274-85. PubMed ID: 16280328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yukmijihwang-tang inhibits receptor activator for nuclear Factor-κB ligand-induced osteoclast differentiation.
    Shim KS; Ma CJ; Kim DS; Ma JY
    J Med Food; 2011 Nov; 14(11):1439-47. PubMed ID: 21883017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling.
    Rahman MM; Bhattacharya A; Fernandes G
    J Lipid Res; 2006 Aug; 47(8):1739-48. PubMed ID: 16702601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of upstream stimulatory factors 1 and 2 in RANKL-induced transcription of tartrate-resistant acid phosphatase gene during osteoclast differentiation.
    Liu Y; Shi Z; Silveira A; Liu J; Sawadogo M; Yang H; Feng X
    J Biol Chem; 2003 Jun; 278(23):20603-11. PubMed ID: 12663664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell adhesion signaling regulates RANK expression in osteoclast precursors.
    Mochizuki A; Takami M; Miyamoto Y; Nakamaki T; Tomoyasu S; Kadono Y; Tanaka S; Inoue T; Kamijo R
    PLoS One; 2012; 7(11):e48795. PubMed ID: 23139818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
    Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
    Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YY1 is involved in RANKL-induced transcription of the tartrate-resistant acid phosphatase gene in osteoclast differentiation.
    Shi Z; Silveira A; Patel P; Feng X
    Gene; 2004 Dec; 343(1):117-26. PubMed ID: 15563837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of osteoprotegerin on osteoclast formation and function under serum-free conditions.
    Fu YX; Gu JH; Zhang YR; Tong XS; Zhao HY; Yuan Y; Liu XZ; Bian JC; Liu ZP
    J Vet Sci; 2013; 14(4):405-12. PubMed ID: 23820214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High throughput screening identified a substituted imidazole as a novel RANK pathway-selective osteoclastogenesis inhibitor.
    Chen T; Knapp AC; Wu Y; Huang J; Lynch JS; Dickson JK; Lawrence RM; Feyen JH; Agler ML
    Assay Drug Dev Technol; 2006 Aug; 4(4):387-96. PubMed ID: 16945012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities.
    Wittrant Y; Theoleyre S; Couillaud S; Dunstan C; Heymann D; Rédini F
    Exp Cell Res; 2004 Feb; 293(2):292-301. PubMed ID: 14729467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis.
    Gong W; Dou H; Liu X; Sun L; Hou Y
    Clin Exp Pharmacol Physiol; 2012 Oct; 39(10):886-93. PubMed ID: 23013134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.